Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 22 - Dec 5, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
9 Dec 2020

ASH 2020: Targeted therapies in r/r multiple myeloma

Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Meral Beksaç, Dr Shaji Kumar
ASH 2020: Targeted therapies in r/r multiple myeloma ( Prof Marivi Mateos, Prof Meletios Dimopoulos, Prof Meral Beksaç, Dr Shaji Kumar )
8 Dec 2020

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings

Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA
Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings ( Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA )
8 Dec 2020

Five year update of ECHELON-1 for classical Hodgkin lymphoma

Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil
Five year update of ECHELON-1 for classical Hodgkin lymphoma ( Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil )
8 Dec 2020

Off-the-shelf multi-virus specific T cells following haematopoietic stem cell transplantation

Dr Bilal Omer - Baylor College of Medicine, Houston, USA
Off-the-shelf multi-virus specific T cells following haematopoietic stem cell transplantation ( Dr Bilal Omer - Baylor College of Medicine, Houston, USA )
8 Dec 2020

Blinatumomab and oral TKIs for the treatment of Ph ALL

Dr Mark Geyer - Memorial Sloan Kettering Cancer Center, New York, USA
Blinatumomab and oral TKIs for the treatment of Ph  ALL ( Dr Mark Geyer - Memorial Sloan Kettering Cancer Center, New York, USA )
8 Dec 2020

D-ALBA update: Frontline sequential dasatinib and blinatumomab in adult Ph ALL

Dr Mark Geyer - Memorial Sloan Kettering Cancer Center, New York, USA
D-ALBA update: Frontline sequential dasatinib and blinatumomab in adult Ph  ALL ( Dr Mark Geyer - Memorial Sloan Kettering Cancer Center, New York, USA )
8 Dec 2020

Real world management of multiple myeloma patients

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
Real world management of multiple myeloma patients ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
8 Dec 2020

Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia

Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA
Ibrutinib plus venetoclax for first-line treatment of chronic lymphocytic leukaemia ( Dr William Wierda - University of Texas MD Anderson Cancer Center, Houston, USA )
5 Dec 2020

ecancer special issue on immunotherapy

Dr Nicola Fusco and Elham Sajjadi - European Institute of Oncology, Milan, Italy
ecancer special issue on immunotherapy ( Dr Nicola Fusco and Elham Sajjadi - European Institute of Oncology, Milan, Italy )
3 Dec 2020

PARP inhibitors in prostate cancer: A promise delivered

Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA
PARP inhibitors in prostate cancer: A promise delivered ( Dr Abhishek Tripathi - Stephenson Cancer Center, Oklahoma City, USA )
1 Dec 2020

Targeting a KRAS neoantigen peptide vaccine to DNGR-1 dendritic cells

Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom
Targeting a KRAS neoantigen peptide vaccine to DNGR-1  dendritic cells ( Dr Rachel Ambler - The Francis Crick Institute, London, United Kingdom )
27 Nov 2020